Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Differential Affinities of 5-(2-Halogenovinyl)-2'-Deoxyuridines for Deoxythymidine Kinases of Various Origins

Y.-C. CHENG, G. DUTSCHMAN, E. DE CLERCQ, A. S. JONES, S. G. RAHIM, G. VERHELST and R. T. WALKER
Molecular Pharmacology July 1981, 20 (1) 230-233;
Y.-C. CHENG
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. DUTSCHMAN
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. DE CLERCQ
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. S. JONES
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. G. RAHIM
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. VERHELST
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. T. WALKER
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department, University of Birmingham, Birmingham B15 2TT, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The inhibition constants (Ki) of a series of 5-(2-halogenovinyl)-2'-deoxyuridines, including E-5-(2-chlorovinyl)-dUrd, E-5-(2-bromovinyl)-dUrd, E-5-(2-iodovinyl)-dUrd, and Z-5-(2-bromovinyl)-dUrd, have been determined for the dThd kinases of human cytosol or mitochondria, herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), or varicella-zoster virus (VZV). The E-5-(2-halogenovinyl)-2'-deoxyuridines had a much higher affinity for HSV-1 (or VZV) dThd kinase than for HSV-2 dThd kinase, and the affinity of E-5-(2-bromovinyl)-dUrd for HSV-1 dThd kinase was also much higher than that of its stereo-isomer, Z-5-(2-bromovinyl)-dUrd. The relative affinities of these compounds for the virus-induced dThd kinase correlated closely with their inhibitory effects on these viruses, suggesting that the selectivity of E-5-(2-bromovinyl)-dUrd and its congeners toward herpes viruses (HSV and VZV) is to a large extent dependent on their phosphorylation by the virus-induced dThd kinase.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 1
1 Jul 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differential Affinities of 5-(2-Halogenovinyl)-2'-Deoxyuridines for Deoxythymidine Kinases of Various Origins
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Differential Affinities of 5-(2-Halogenovinyl)-2'-Deoxyuridines for Deoxythymidine Kinases of Various Origins

Y.-C. CHENG, G. DUTSCHMAN, E. DE CLERCQ, A. S. JONES, S. G. RAHIM, G. VERHELST and R. T. WALKER
Molecular Pharmacology July 1, 1981, 20 (1) 230-233;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Differential Affinities of 5-(2-Halogenovinyl)-2'-Deoxyuridines for Deoxythymidine Kinases of Various Origins

Y.-C. CHENG, G. DUTSCHMAN, E. DE CLERCQ, A. S. JONES, S. G. RAHIM, G. VERHELST and R. T. WALKER
Molecular Pharmacology July 1, 1981, 20 (1) 230-233;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
  • EIPA, HMA and SMN2 gene regulation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics